Developers of Oxford-AstraZeneca Vaccine Tied to UK Eugenics Movement
By Jeremy Loffredo and Whitney Webb |
Unlimited Hangout| December 26, 2020
The developers of the Oxford-AstraZeneca vaccine have previously undisclosed ties to the re-named British Eugenics Society as well as other Eugenics-linked institutions like the Wellcome Trust.
On April 30th, AstraZeneca and Oxford University announced a “landmark agreement” for the development of a COVID-19 vaccine. The agreement involves AstraZeneca overseeing aspects of the development as well as manufacturing and distribution while the Oxford side, via the Jenner Institute and Oxford Vaccine Group, researched and developed the vaccine. Less than a month after this agreement was reached, the Oxford-AstraZeneca partnership was awarded a contract from the US government as part of Operation Warp Speed, the public-private COVID-19 vaccination effort dominated by the US military and US intelligence.
Though the partnership was announced in April, Oxford’s Jenner Institute had already begun developing the COVID-19 vaccine months before, in mid-January. According to a recent BBC report, it was in January that the Jenner Institute first became aware of how serious the pandemic would soon become, when Professor Andrew Pollard, who works for both the Jenner Institute and heads the Oxford Vaccine Group, “shared a taxi with a modeler who worked for the UK’s Scientific Advisory Group for Emergencies.” During the taxi ride, “the scientist told him data suggested there was going to be a pandemic not unlike the 1918 flu.” Due to this sole encounter, we are told, the Jenner Institute then began to pour millions into the early development of a vaccine for COVID-19 well before the scope of the crisis was clear.
For much of 2020, the Oxford-AstraZeneca vaccine was treated as an early front-runner, though its lead would later be marred by scandals related to its clinical trials, including the death of participants, sudden trial pauses, the use of a problematic “placebo” with its own host of side effects and the “unintentional” mis-dosing of some participants that skewed its self-reported efficacy rate.
The significant issues that emerged during trials have provoked little concern from the vaccine’s two lead developers, despite critical attention from even mainstream media of its complications. The lead developer of the Oxford-AstraZeneca vaccine, Adrian Hill, told NBC on December 9th that the experimental vaccine should be approved and distributed to the public before the conclusion of the safety trials, saying,”to wait for the end of the trial would be the middle of next year. That’s too late, this vaccine is effective, available at large scale and easily deployed.”
Sarah Gilbert, the other lead researcher on the vaccine, seemed to believe that pre-mature safety approval was likely, telling the BBC on December 13 that the chances of rolling out the vaccine by the end of the year are “pretty high.” Now, the UK is expected to approve the Oxford-AstraZeneca vaccine shortly after Christmas, with India also set to approve the vaccine next week.
While the controversies surrounding the vaccine’s trials did ultimately undermine its previous frontrunner status, the Oxford-AstraZeneca vaccine remains heavily promoted as the vaccine of choice for the developing world, as it is cheaper and has much less complicated storage requirement than its main competitors, Pfizer and Moderna.
Earlier this month, Dr. Richard Horton, the editor-in-chief of the Lancet medical journal, told CNBC that “The Oxford AstraZeneca vaccine is the vaccine right now that is going to be able to immunize the planet more effectively, more rapidly than any other vaccine we have” in large part because it is a “vaccine that can get to lower middle-income countries.” CNBC also quoted Andrew Baum, global head of health care for Citi Group, as saying that the Oxford-AstraZeneca vaccine “is really the only vaccine that is going to suppress or even eradicate SARS-CoV-2, the virus that causes COVID-19, in the many millions of individuals in the developing world.”
In addition to longstanding claims that the Oxford-AstraZeneca vaccine will be the vaccine of choice for the developing world, this vaccine candidate has also been treated by several outlets in the mainstream and even independent media as “good for people, bad for profits” due to the partnership’s “explicit intention of supplying [the vaccine] around the world on a not-for-profit basis, meaning that the poorest nations on the planet will not have to worry about being shut out of a cure due to lack of funds.”
However, investigation into the vaccine’s developers and the realities of their “no-profit pledge” reveals a very different story than that which has been spun for most of the year by corporate press releases, experts and academics tied to the vaccine and the mainstream press.
For instance, mainstream media has had little, if anything, to say about the role of the vaccine developers’ private company – Vaccitech – in the Oxford-AstraZeneca partnership, a company whose main investors include former top Deutsche Bank executives, Silicon Valley behemoth Google and the UK government. All of them stand to profit from the vaccine alongside the vaccine’s two developers, Adrian Hill and Sarah Gilbert, who retain an estimated 10% stake in the company. Another overlooked point is the plan to dramatically alter the current sales model for the vaccine following the initial wave of its administration, which would see profits soar, especially if the now obvious push to make COVID-19 vaccination an annual affair for the foreseeable future is made reality.
Yet, arguably most troubling of all is the direct link of the vaccine’s lead developers to the Wellcome Trust and, in the case of Adrian Hill, the Galton Institute, two groups with longstanding ties to the UK Eugenics movement. The latter organization, named for the “father of eugenics” Francis Galton, is the re-named UK Eugenics Society, a group notorious for its promotion of racist pseudoscience and efforts to “improve racial stock” by reducing the population of those deemed inferior for over a century.
The ties of Adrian Hill to the Galton Institute should raise obvious concerns given the push to make the Oxford-AstraZeneca vaccine he developed with Gilbert the vaccine of choice for the developing world, particularly countries in Latin America, South and Southeast Asia and Africa, the very areas where the Galton Institute’s past members have called for reducing population growth.
In the final installment of this series on Operation Warp Speed, the US government’s vaccination effort, and race, the Oxford-AstraZeneca vaccine’s ties to Eugenics-linked institutions, the secretive role of Vaccitech, and the myth of the vaccine’s sale being “non-profit” and altruistically motivated are explored in detail.
GlaxoSmithKline and the Jenner Institute
The Edward Jenner Institute for Vaccine Research was initially established in 1995 in Compton in Berkshire as a public-private partnership between the UK government, via the Medical Research Council and the Department of Health, and the pharmaceutical giant GlaxoSmithKline. Following a “review by the [institute’s] sponsors,” it was relaunched in 2005 in Oxford under the leadership of Adrian Hill, who—prior to that appointment—held a senior position at the Wellcome Trust’s Centre for Human Genetics. Hill, the lead developer of the Oxford-AstraZeneca COVID-19 vaccine, still leads a research group at Wellcome aimed at “understand[ing] the genetic basis of susceptibility to different infectious diseases, especially. . . severe respiratory infections,” which conducts most of its studies in Africa. The UK’s Medical Research Council has also become a collaborator with the Wellcome Trust, specifically on vaccine-related initiatives. The Wellcome Trust, discussed at greater length later in this article, was originally created with funding from Henry Wellcome, who founded the company that later became GlaxoSmithKline.
Hill’s partner at the Jenner Institute and the other co-developer of the Oxford COVID-19 vaccine is Sarah Gilbert. Gilbert also hails from the Wellcome Trust, where she was a “program director,” and is a student of Hill’s. Together, Gilbert and Hill have worked to position the institute to be the center of all future vaccination efforts undertaken in response to global pandemics.
Professor Sarah Gilbert at Oxford, Photo by John Cairns
The Jenner Institute’s relocation to Oxford was largely facilitated by the Medical Research Council, which donated £1.25 million between 2005 and 2006, after the decision was made to replace the institute’s original sponsors (GlaxoSmithKline, the Medical Research Council, the Department of Health) with the University of Oxford and the Institute for Animal Health, now called the Pirbright Institute. The involvement of Pirbright meant that the relaunched Jenner Institute became unique in developing vaccines for both humans and livestock.
The relaunched Jenner Institute has come to dominate publicly funded vaccine development in the UK as well as the testing of vaccines produced by the world’s largest pharmaceutical companies via clinical trials and has overseen prominent safety trials for vaccines of high media interest in recent years. Some of the Jenner Institute–conducted trials later drew controversy, such as those using South African infants in 2009 in which seven infants died.
An investigation conducted by the British Medical Journal found that the Hill-led Jenner Institute had, in the South African instance, knowingly misled parents about the negative results of and questionable methods used in animal studies as well the vaccine being known to be ineffective. The vaccine in question, an experimental tuberculosis vaccine developed jointly by Emergent Biosolutions and the Jenner Institute, was scrapped after the controversial study in infants confirmed what was already known, that the vaccine was ineffective. The trial, largely funded by Oxford and the Wellcome Trust, was subsequently praised as “historic” by the BBC. Hill, at the time the study was conducted, had a personal financial stake in the vaccine.
Similar instances of dodgy practices in efficacy trials and the effects of increased dosages have led vaccine experts to criticize the COVID-19 vaccine developed by Hill and Gilbert. Hill and Gilbert hold a considerable financial stake in the Oxford-AstraZeneca COVID-19 vaccine. While the vaccine reportedly has an efficacy of over 90 percent, those figures—often cited in mainstream reports—are self-reported by the vaccine’s developers and manufacturers (i.e., the Oxford team and AstraZeneca), which is significant given that Hill and other Jenner Institute scientists have previously been caught manipulating trial results to benefit a vaccine product in which they were personally invested.
The prominence of the Jenner Institute in vaccine development and testing has largely come through Hill’s additional leadership role at the UK’s Vaccines Network, which chooses what vaccines to develop, how to develop them, and which firms should receive “targeted investments” from the UK government. The Vaccines Network also plays a key role in identifying “what vaccine technologies could play an important role in future outbreaks.” Two of the main backers of the UK’s Vaccines Network are the Wellcome Trust and GlaxoSmithKline.
Unsurprisingly, the Vaccines Network has steered many millions of pounds toward the Hill-run Jenner Institute, with completed projects including a “plug and display” virus-like particle platform for rapid-response vaccination. Also funded by the Vaccines Network were the Jenner Institute’s initial studies of novel chimpanzee adenovirus vaccines for coronavirus (in this case, MERS), the same viral vector used for the Oxford-AstraZeneca vaccine. In addition to the Vaccines Network, the Jenner Institute also coordinates the efforts of the EU’s Vaccines Network equivalent, MultiMalVax.
Professor Adrian Hill at the Jenner Institute, Photo by John Cairns
The Jenner Institute also has a close relationship with GlaxoSmithKline and the Italian biotech Okairos, which was acquired by GlaxoSmithKline in 2014. Soon after it was acquired, Okairos, and its new owner GlaxoSmithKline, became key players in the 2014 experimental Ebola vaccine push, an effort that mirrors the current COVID-19 vaccine development rush in many key ways. The rushed safety trials for that vaccine were overseen by Adrian Hill and the Jenner Institute and funded by the UK government and the Wellcome Trust. GlaxoSmithKline and Okairos are the only firms represented on the Jenner Institute’s Scientific Advisory Board.
The Jenner Institute, along with GlaxoSmithKline-Okairos and a small French biotech called Imaxio, have been developing an experimental malaria vaccine since 2015, with human trials of that vaccine announced on December 12, 2020. Those trials will be conducted on 4,800 children in Africa over the course of 2021, in many of the same countries where Hill’s research group at the Wellcome Center for Human Genetics has been studying genetic susceptibility to several diseases. “A lot more people will die in Africa this year from malaria than will die from Covid,” Hill recently said in regard to the soon-to-begin trials.
Currently, the Jenner Institute is funded by the Jenner Vaccine Foundation, but the foundation’s documents note on several occasions a considerable influx of money from Wellcome Trust Strategic Awards. A “special review panel” from the Wellcome Trust actually lobbied the Jenner Institute to apply for further “strategic core funding” from the trust after visiting the institute and appraising its work. The Jenner Institute frames its funding from Wellcome as the key guidance behind its development decisions, which are made “based on the successful model of Wellcome Trust Strategic Award support.”
The Jenner Institute’s foundation, however, is not the only source of income for its lead researchers. Hill and Gilbert have been working to commercialize many of the institute’s vaccines through their own private company, Vaccitech. Though media reports often describe the vaccine as being a joint effort between AstraZeneca and the University of Oxford, Vaccitech is a key stakeholder in that partnership, given that the vaccine candidate relies on technology developed by Hill and Gilbert and owned by Vaccitech. A deeper look into Vaccitech offers a clue as to why the company’s name has been absent from nearly all media reports on the Oxford-AstraZeneca vaccine, as it demolishes the much-touted claim that the vaccine is “nonprofit” and offered at low cost for charitable reasons.
Vaccitech: doing well by going “good”?
The official reason Sarah Gilbert and Adrian Hill created Vaccitech in 2016 per The Times is because “Oxford’s researchers [are] encouraged to form companies to commercialize their work.” Vaccitech, like other “commercialized” Oxford research enterprises, was spun out of the Jenner Institute via the university’s commercialization arm, Oxford Science Innovations, which is currently Vaccitech’s largest stakeholder at 46 percent. Hill and Gilbert are reported to maintain a 10 percent stake in the company.
The largest investor in Oxford Science Innovations, and by extension one of the largest shareholders in Vaccitech, is Braavos Capital, the venture-capital firm started in 2019 by Andrew Crawford-Brunt, Deutsche Bank’s long-time global head of equity trading at its London branch. Through its stake in Oxford Science Innovations, Braavos owns about 9 percent of Vaccitech.
Prior to COVID-19, Vaccitech’s main focus, especially last year, was the development of a universal vaccine for the flu. Vaccitech’s efforts in this regard were praised by Google, which is also invested in Vaccitech. At the same time, the Bill & Melinda Gates Foundation was funding research to develop a universal flu vaccine, reportedly because the field of influenza vaccinology was not yet able “to design a flu vaccine that would protect broadly against the strains of flu that infect people every winter and those in nature that could emerge to trigger a disruptive and deadly pandemic,” according to a STAT News report from last year. The Gates Foundation effort originally partnered with Google’s cofounder Larry Page and his wife Lucy.
To fully finance Hill and Gilbert’s Vaccitech, and specifically its quest to develop a universal flu vaccine, Oxford Science Innovations sought £600 million from “outside investors,” chief among them the Wellcome Trust and the venture-capital arm of Google, Google Ventures. This means that Google is poised to make a profit from the Oxford-AstraZeneca vaccine at a time when its video platform YouTube has moved to ban COVID-19 vaccine–related content that shines a negative light on COVID-19 vaccines, including the Oxford-AstraZeneca candidate. Other investors in Vaccitech include Sequoia Capital’s Chinese branch and the Chinese pharmaceutical company Fosun Pharma. In addition, the UK government has put an estimated £5 million into the company and is also expected to make a return on the Oxford-AstraZeneca vaccine.
Vaccitech’s homepage showing company co-founders Adrian Hill and Sarah Gilbert. From vaccitech.co.uk
Information on the profit motive behind the Oxford-AstraZeneca vaccine has been muddied due to the extensive media promotion of the claim that Hill and Gilbert will not be collecting royalties on the vaccine and that AstraZeneca is not making a profit off the vaccine. However, this is only true until the pandemic is “officially” declared over, and the virus is labeled a persistent or seasonal condition that will require the mass administration of COVID-19 vaccines at regular intervals and possibly annually. Sky News reported that the determination of when the pandemic is over “will be based on the views of a range of [unspecified] independent bodies.” At that point, both Vaccitech and Oxford will obtain royalties from AstraZeneca’s sales of the vaccine.
Those tied to the vaccine have been at the center of promoting the idea that the COVID-19 vaccine will soon become an annual affair. For instance, in early May, John Bell—an Oxford medical professor and an “architect” of the Oxford-AstraZeneca partnership—told NBC News, “I suspect we may need to have relatively regular vaccinations against coronaviruses going into the future,” adding that the vaccine would likely be needed every year like the flu vaccine. NBC News failed to note that the Oxford-AstraZeneca vaccine in which Bell is involved stands to significantly benefit financially if that does come to pass.
More recently, Bell told The Week that, “should there prove to be a market for regular vaccinations against coronavirus in the future, ‘there is some money to be made.’” Such sentiments have been echoed by Pascal Soriot, the CEO of AstraZeneca, who told Bloomberg last month that the company stood to make a “reasonable profit” once the pandemic was declared over and COVID-19 deemed a seasonal illness requiring regular vaccinations. On this matter, Vaccitech’s CEO, Bill Enright, stated that Vaccitech investors would receive a “big chunk of the royalties from a successful vaccine as well as ‘milestone’ payments” if and when the pandemic is declared over and COVID-19 vaccines become a seasonal event.
Vaccitech, in particular, appears quite certain that this possibility is slated to become reality. For all subsequent iterations of the Oxford-AstraZeneca vaccine, Vaccitech will reacquire a much larger percentage of rights to the vaccine, rights it is currently splitting with Oxford for the first iteration. Sky News has noted that the technology that Vaccitech owns “could drive the second generation of COVID-19 vaccines” and that it “has [already] received £2.3 million of public funding to develop it.”
US government officials such as Anthony Fauci have also signaled that the COVID-19 vaccine will require annual shots. Notably, the government, through Health and Human Service’s BARDA, has poured over $1 billion into the Oxford-AstraZeneca vaccine development. In addition to government officials, several recently published mainstream media reports have claimed that the “expert” consensus “seem[s] to be leaning toward an annual shot like the flu vaccine” with regards to the COVID-19 vaccine. For instance, Dr. Charles Chiu, a professor of infectious diseases at the University of California–San Francisco, recently told Salon, “This may end up being a vaccine that’s not a one-time thing or even a two-time thing. . . it may end up being what we call either a seasonal vaccine, or vaccine that needs to be administered every couple of years.”
Such hints about an annual COVID-19 vaccine from 2021 onward have recently become commonplace from the leading COVID-19 vaccine manufacturers themselves. For instance, on December 13th, Pfizer CEO Albert Bourla was quoted by the Telegraph as saying, “How long this [vaccine] protection lasts is something we don’t know … I think it is a likely scenario that you will need periodical vaccinations.” Pfizer also recently issued a statement that noted that “we don’t know how the virus will change, and we also don’t know how durable the protective effect of any vaccination will be,” adding that its vaccine would be suitable “for repeated administration as booster shots” in the event that the vaccine only induces an immune response for a few months.
Then, this past Tuesday, Moderna released information that suggested immunity from its COVID-19 vaccine would only last several months, with Forbes writing that “the duration of neutralizing antibodies from the Moderna vaccine will be relatively short, potentially less than a year,” an outcome that would favor the push for an annual COVID-19 shot. The developer of the Pfizer COVID-19 vaccine, Ugur Sahin of BioNTech, also stated on Tuesday that “The virus will stay with us for the next 10 years… We need to get used to the fact there’ll be more outbreaks.” He later added that “if the virus becomes more efficient… we might need a higher uptake of the vaccine for life to return to normal,” implying that these regular outbreaks he foresees occurring over the next ten years would be correlated with increased vaccine administration.
Quotes from the developers of the Oxford-AstraZeneca vaccine themselves also point to a pandemic-dominated future and a desire for the crisis to be prolonged so that the vaccine can be widely distributed. Gilbert told the UK Independent in August that she believes COVID-19 is just the beginning and that COVID-like pandemics will become more frequent in the near future. The Jenner Institute vaccine team seems so determined to create the COVID vaccine that, in June, Hill was quoted by the Washington Post in June as stating that he wanted the pandemic to stick around, saying, “We’re in the bizarre position of wanting COVID to stay, at least for a little while. But cases are declining.” He also stated that his team was in “a race against the virus disappearing.”
With the vaccine developers, “medical experts,” government officials, and the CEOs of major vaccine manufacturers all agreeing that a seasonal COVID-19 vaccine is an increasingly likely outcome, it is worth considering a possible ulterior motive regarding the initial “nonprofit” model being used by the Jenner Institute/Vaccitech and AstraZeneca for their joint COVID-19 vaccine.
Given that vaccine guidance in several countries states that each dose of the multidose COVID-19 vaccine must be produced by the same manufacturer as previous doses, the implication is that in the event of a need for periodic COVID-19 vaccine variants, those who initially received the Oxford-AstraZeneca vaccine would likely be required to receive that same “brand” of vaccine seasonally. In other words, those who initially received the Oxford-AstraZeneca vaccine would likely be required, not just to receive a second dose of the same “brand,” but continue receiving that same “brand” of vaccine every year. Notably, no interaction studies have yet been conducted on the interactions between the COVID-19 vaccines and other medications as well as other vaccines.
If this turns out to be the case, it would certainly behoove the Oxford-Vaccitech-AstraZeneca team to want their vaccine to be the most widely used one in the first year in order to guarantee the largest market for subsequent annual COVID-19 vaccines. This could be a possible motive behind the efforts of the Oxford-AstraZeneca partnership “to supply the entire world with the Oxford jab” and to supply the vaccine “to the most vulnerable groups to COVID-19.” This vaccine has already been purchased, even before regulatory approval, by governments around the world, including in Europe, North America, Australia and most Latin American countries.
The Wellcome Trust
Adrian Hill currently holds a senior position at the Wellcome Trust’s Centre for Human Genomics. The Wellcome Trust is a scientific charity based in London, established in 1936 with funds from pharmaceutical magnate Henry Wellcome. As previously mentioned, Wellcome founded the pharmaceutical company that eventually became the industry giant GlaxoSmithKline. Today, the Wellcome Trust has a $25.9 billion endowment and engages in philanthropic endeavors, including funding clinical trials and research.
Hill has been closely tied to Wellcome for decades. In 1994, he participated in the founding of the Wellcome Centre for Human Genetics and was awarded a Wellcome Trust Principal Research Fellowship the following year. He became a Wellcome professor of human genetics in 1996.
The Wellcome Centre for Human Genetics website boasts of the large-scale genetic mapping they’ve conducted in Africa. The center also publishes papers that explore genetic dispositions in relation to male fertility and “reproductive success.” The crossroads between race and genes is important in the center’s work, as an entire working group at the center, the Myers Group, is dedicated to mapping the “genetic impacts of migration events.” The center also funded a paper that argued that so long as eugenics is not coercive it’s an acceptable policy initiative. The paper asks, “Is the fact that an action or policy is a case of eugenics necessarily a reason not to do it?” According to Hill’s page on the Wellcome Trust site, race and genetics have long played a central role in his scientific approach, and his group currently focuses on the role genetics plays in African populations with regard to susceptibility to specific infectious diseases.
The Wellcome Genome Campus, which houses the Wellcome Centre for Human Genetics, is located on the grounds of Hixton Hall, in Cambridgeshire, England.
Of even greater concern, last year Science Mag reported that Wellcome was accused by both a whistleblower and the University of Cape Town South Africa of illegally exploiting hundreds of Africans by “commercializing a gene chip without proper legal agreements and without the consent of the hundreds of African people whose donated DNA was used to develop the chip.” Jantina de Vries, a bioethicist at the University of Cape Town South Africa told the journal that it was “clearly unethical.” Since the controversy, other African institutions and peoples such as the indigenous Nama peoples of Namibia have demanded that Wellcome return the DNA it collected.
The Wellcome Centre regularly co-funds the research and development of vaccines and birth control methods with the Gates Foundation, a foundation that actively and admittedly engages in population and reproductive control in Africa and South Asia by, among other things, prioritizing the wide-spread distribution of injectable long-acting, reversible contraceptives (LARCs). The Wellcome Trust has also directly funded studies that sought to develop methods to “improve uptake” of LARCs in places such as rural Rwanda.
As researcher Jacob Levich wrote in the Palgrave Encyclopedia of Imperialism and Anti-Imperialism, LARCs afford women in the Global South “the least choice possible short of actual sterilization.” Some LARCs can render women infertile for as long as five years, and, as Levich argues, they “leave far more control in the hands of providers, and less in the hands of women, than condoms, oral contraceptives, or traditional methods.”
One example is Norplant, a contraceptive implant manufactured by Schering (now Bayer) that can prevent pregnancy for up to five years. It was taken off the US market in 2002 after more than fifty thousand women filed lawsuits against the company and the doctors who prescribed it. Seventy of those class action suits were related to side effects such as depression, extreme nausea, scalp-hair loss, ovarian cysts, migraines, and excessive bleeding.
Slightly modified and rebranded as Jadelle, the dangerous drug was promoted in Africa by the Gates Foundation in conjunction with USAID and EngenderHealth. Formerly named the Sterilization League for Human Betterment, EngenderHealth’s original mission, inspired by racial eugenics, was to “improve the biological stock of the human race.” Jadelle is not approved by the FDA for use in the United States.
Another scandal-ridden LARC is Pfizer’s Depo-Provera, an injectable contraceptive used in several African and Asian countries. The Gates Foundation and USAID have collaborated to fund this drug’s distribution and introduce it into the health-care systems of countries including Uganda, Burkina Faso, Nigeria, Niger, Senegal, Bangladesh, and India.
Andrew Pollard, director of the Oxford Vaccine Group, where Hill’s Jenner Institute resides, is enmeshed with the Gates Foundation. His employer, the University of Oxford, has received $11 million for vaccine development research from the foundation over the past three years and $208 million in grants over the past decade. In 2016, the Gates Foundation gave $36 million to a team of researchers that was headed by Pollard for vaccine development. In addition, Pollard’s private laboratory is funded by the Gates Foundation. Given this, it should come as no surprise that the Global Alliance for Vaccine Initiative (GAVI), a public-private partnership founded and currently funded by the Bill & Melinda Gates Foundation, plans to distribute the Oxford-AstraZeneca COVID-19 vaccine to low-income, predominantly African and Asian, countries once it’s approved.
The Galton Institute: Eugenics for the Twenty-First Century
Both the Wellcome Trust and Adrian Hill share a close relationship with the most infamous eugenics society in Europe, the British Eugenics Society. The Eugenics Society was renamed the Galton Institute in 1989, a name that pays homage to Sir Francis Galton, the so-called father of eugenics, a field that he often described as the “science of improving racial stock.”
In the case of the Wellcome Trust, the Trust’s library is the guardian of the Eugenics Society historical archives. When the Wellcome Trust first set up its Contemporary Medical Archive Center, the first organizational archive it sought to acquire was tellingly that of the Eugenics Society-Galton Institute. Wellcome’s website describes the Eugenics Society’s original purpose as “to increase public understanding of heredity and to influence parenthood in Britain, with the aim of biological improvement of the nation and mitigation of the burdens deemed to be imposed on society by the genetically ‘unfit’.” It also states the interests of the society’s members “ranged from the biology of heredity, a subject that developed rapidly during the first half of the 20th century, to the provision of birth control methods, artificial insemination, statistics, sex education and family allowances.” Lesley Hall, Wellcome’s senior archivist, has referred to Francis Galton, a racist eugenicist, as an “eminent late nineteenth century polymath” in her discussion of the Eugenics Society archive held at Wellcome.
A poster published by the Eugenics Society-Galton Institute in the 1930S, from the Wellcome Library
Several top governance positions at the former British Eugenics Society, now the Galton Institute, include individuals who originally worked at The Wellcome Trust, including the Galton Institute’s president Turi King. Dr. Elena Bochukova, a current Galton Council Member and Galton lecturer, previously worked under the direction of Adrian Hill at the Wellcome Trust Center for Human Genetics. The Galton Institute’s Senior Genetics Researcher, Dr. Jess Buxton, was previously a ‘genetics researcher’ at the Wellcome Trust and then went on to carry out independent research financed by Wellcome. Her research, which is particularly race oriented, includes creating the first genetic sequence map of a native Nigerian. Moreover, Adrian Hill himself spoke at the Eugenics Society-Galton Institute at the celebration of their 100th anniversary in 2008.
The Galton Institute publishes what they now call the Galton Review, previously titled the Eugenics Review, where various members of the self-proclaimed “learned society” publish papers focused on population issues, genetics, evolutionary biology, and fertility.
A look at early issues of the Eugenics Review shines a light on Galton’s original ambitions. In the 1955 issue titled “The Immigration of Colored People,” an author asks, “What will become of our national character, good workmanship etc. in the course of a few decades if this immigration of negroes and negroids continues unchecked?” The article ends with an appeal to readers to write their parliamentary representatives and urge them that in view of “racial betterment or deterioration” something must be done urgently to “check the present influx of africans and other negroids.”
Today, it appears that the Galton Institute continues to see the immigration of racial minorities into European cities as an unchecked threat. Mike Coleman, an Oxford professor of demographics and a fellow at the institute runs an anti-immigration organization and advocacy group called MigrationWatch—whose mission is to preserve the European culture of the UK by lobbying the government to stem legal immigration and publishing data that supposedly demonstrates the biological and cultural threat of increasing immigration.
A 1961 issue of the Eugenics Review titled “The Impending Crisis” claims the function of the institute’s upcoming conference is “to honor Margaret Sanger” and describes the population crisis as “quantity threatening quality.”
Sanger, known as the “pioneer of the American birth control movement,” was a staunch advocate for promoting “racial betterment” and the key architect of the Negro Project, which she claimed “was established for the benefit of the colored people.” But as medical ethics fellow at Harvard Medical School, Harriet Washington, argues in her book Medical Apartheid, “The Negro Project sought to find the best way to reduce the black population by promoting eugenic principals.” Sanger was an American member of the British Eugenics Society.
Another early member of the Galton Institute was John Harvey Kellogg, prominent business man and eugenicist. Kellogg founded the Race Betterment Foundation and argued that immigrants and nonwhites would damage the American gene pool. Yet another example is Charles Davenport, a scientist known for his collaborative research efforts with eugenicists in Nazi Germany and his contributions to Nazi Germany’s brutal racial policies, who was vice president of the Galton Institute in 1931.
Another more recent member of the Galton Institute was David Weatherall, for whom the Weatherall Institute of Molecular Medicine at Oxford is named. Weatherall was a member of the Galton Institute when it was still named the Eugenics Society and he remained a member until his death in 2018. Weatherall, who was knighted by the British monarch in 1987 for his contributions to science, addressed the Galton Institute on numerous occasions and gave a senior lecture on genetics at the institute in 2014, of which no transcript or video is available. As an Oxford professor, Weatherall was Adrian Hill’s doctoral adviser and eventually his boss when Hill began working at the Weatherall Institute conducting immunogenic research in Africa. A key fixture of the Weatherall Institute of Molecular Medicine since its founding is Walter Bodmer, a former president of the Galton Institute.
While the Galton Institute has attempted to distance itself from its past of promoting racial eugenics with surface-level public relations efforts, it has not stopped family members of the infamous racist from achieving leadership positions at the institute. Emeritus professor of molecular genetics at the Galton Institute and one of its officers is none other than David. J Galton, whose work includes Eugenics: The Future of Human Life in the 21st Century. David Galton has written that the Human Genome Mapping Project, originally dreamt up by Galton’s former president Walter Bodmer, had “enormously increased . . . the scope for eugenics . . . because of the development of a very powerful technology for the manipulation of DNA.”
This new “wider definition of eugenics,” Galton has said, “would cover methods of regulating population numbers as well as improving genome quality by selective artificial insemination by donor, gene therapy or gene manipulation of germ-line cells.” In expanding on this new definition, Galton is neutral as to “whether some methods should be made compulsory by the state, or left entirely to the personal choice of the individual.”
Who gets the safest vaccines?
Considering the degree to which the players and institutions behind the Oxford-AstraZeneca vaccine (including the lead developer) are tied and connected to institutions that have been instrumental in the rise and perpetuation of racial eugenics, it’s concerning that this particular vaccine is being portrayed by scientists and media alike as the COVID-19 vaccine for the poor and the Global South.
The Oxford-AstraZeneca vaccine sells at a fraction of the cost of its COVID-19 vaccine competitors—running between 3 and 5 dollars per dose. Moderna and Pfizer cost 25 to 37 dollars and 20 dollars per dose, respectively. As CNN recently reported, the Oxford-AstraZeneca vaccine will “be far easier to transport and distribute in developing countries than its rivals,” several of which require complicated and costly cold supply chains. When the Thomson Reuters Foundation asked several experts which COVID-19 vaccine could “reach the poorest soonest,” all declared a preference for the Oxford-AstraZeneca candidate.
There is also the added fact that a host of safety issues have come to surround the vaccine. Recently, on November 21, a forty-year-old participant in AstraZeneca’s clinical trial who lives in India sent a legal notice to the Serum Institute of India alleging that the vaccine caused him to develop acute neuroencephalopathy, or brain damage. In the notice, the participant said he “must be compensated, in the least, for all the sufferings that he and his family have undergone and are likely to undergo in the future.”
In response, the Serum Institute claimed the participant’s medical complications are unrelated to the vaccine trial and said it would take “legal action” against the brain-damaged participant for maligning the company’s reputation, seeking damages in excess of $13 million. “This is the first time I have ever heard of a sponsor threatening a trial participant,” Amar Jesani, editor of the Indian Journal of Medical Ethics, said of the incident. The Serum Institute has received at least $18.6 million from the Bill & Melinda Gates Foundation and has a deal with AstraZeneca to manufacture a billion doses of the vaccine.
Other manufacturers chosen by Oxford-AstraZeneca to produce their vaccine are also no strangers to controversy. For instance, their manufacturing partner in China, Shenzhen Kangtai Biological Products, has been at the center of controversy for years, especially after 17 infants died from its Hepatitis B vaccine in 2013. The New York Times cited Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations, as saying: “Imagine if a similar scandal is reported again in China… It’s not just going to undermine the confidence of the company manufacturing the vaccine, it’s also going to hurt the reputation of AstraZeneca itself and their vaccine, too.”
In another example, the manufacturing partner chosen to produce the vaccine in the US is the scandal-ridden company with ties to the 2001 anthrax attacks, Emergent Biosolutions. Emergent Biosolutions, previously known as BioPort, has a long track record of knowingly selling and marketing products that were never tested for safety and efficacy, including its anthrax vaccine BioThrax and its biodefense product Trobigard. The current head of quality control for Emergent Biosolutions’ lead manufacturing facility in the US has no expertise in pharmaceutical manufacturing and is instead a former high-ranking military intelligence official who operated in Iraq, Afghanistan and beyond.
The issues raised by their decision to partner with manufacturers with dark histories of product safety issues are compounded by the adverse reactions reported in the Oxford-AstraZeneca trials as well as the ways in which those trials have been conducted. In September, AstraZeneca was forced to pause its experimental COVID-19 vaccine trial after a woman in the UK developed a “suspected serious reaction” that the New York Times reported was consistent with transverse myelitis. TM is a neurological disorder characterized by inflammation of the spinal cord, a major element of the central nervous system. It often results in weakness of the limbs, problems emptying the bladder, and paralysis. Patients can become severely disabled, and there is currently no effective cure.
Concern over an association between TM and vaccines is well established. A review of published case studies in 2009 documented thirty-seven cases of TM associated with various vaccines, including hepatitis B, measles-mumps-rubella, diphtheria, pertussis, tetanus, among others in infants, children, and adults. The researchers in Israel noted, “The associations of different vaccines with a single autoimmune phenomenon allude to the idea that a common denominator of these vaccines, such as an adjuvant, might trigger this syndrome.” Even the New York Times article on the AstraZeneca trial pause notes past “speculation” that vaccines might be able to trigger TM.
In July, an Oxford-AstraZeneca trial participant developed symptoms of TM, and the vaccine trial was paused at that time. An “independent panel” ultimately concluded the illness was unrelated to the vaccine, and the trial continued. Yet, as Nikolai Petrovsky from Flinders University told the Australian Broadcasting Corporation, these panels are typically made up of “biostatisticians and also medical representatives from the sponsor drug company running the trial.” Then, in October, a trial participant in Brazil died, though in that case, AstraZeneca suggested that the person was part of the control group and thus hadn’t received the COVID-19 vaccine.
According to Forbes, the AstraZeneca vaccine was ineffective at stopping the spread of coronavirus in their animal trials. All six monkeys injected with AstraZeneca’s COVID-19 vaccine became infected with the disease after being inoculated. All the monkeys were put to death, which means that it will remain unknown whether those monkeys would have suffered other adverse effects.
Another concern is that trial administrators gave the trial control group (for both human and animal trials) Pfizer’s Nimenrix, a meningitis vaccine, as opposed to a saline solution, which is regarded as the gold standard for controls because researchers can be sure the saline solution won’t cause any adverse reactions. Using Pfizer’s meningitis vaccine as the control placebo allows AstraZeneca to downplay any adverse reactions in its COVID-19 vaccine group by showing that the control group suffered adverse reactions as well. “The meningitis vaccine in the AstraZeneca trial is what I would call a ‘fauxcebo,’ a fake control whose real purpose is to disguise or hide injury in the vaccine group,” said Mary Holland, general counsel at Children’s Health Defense.
Eugenics under another name
Despite these safety concerns and clinical trial scandals, close to 160 countries have purchased the Oxford-AstraZeneca vaccine, and now reports are suggesting that India, the country with the second largest population on Earth, is likely to approve this vaccine by next week.
As documented here, while the vaccine may be heralded as “vital for lower-income countries,” the Oxford-AstraZeneca project is no mere philanthropic pursuit. Not only is there a significant profit motive behind the vaccine, but its lead researcher’s connection to the British Eugenics Society adds another level of warranted scrutiny.
For those encountering stories of eugenicists, it’s common to dismiss such activity as that of “conspiracy theories.” However, it’s undeniable that several prominent individuals and institutions that remain active today have clear ties to eugenicist thinking, which was not so taboo just a few decades ago. Unfortunately, this holds true for the individuals and institutions associated with the Oxford-AstraZeneca COVID vaccine, who, as demonstrated in this article, immerse themselves in studies of race science and population control – primarily in Africa while working closely with institutions that have direct and longstanding links to the worst of the Eugenics movement.
As this series has shown, there are many concerns regarding the points where race and the COVID-19 vaccination campaign in the US and abroad intersect, both publicly and privately. Part I of this series raised questions about the policy-shaping role of the Johns Hopkins Center for Health Security, which suggested that the US government make COVID-19 vaccines available to ethnic minorities and the mentally challenged first. Part II explained how in order to allocate COVID-19 vaccines in the US, health agencies are using a program created by Palantir, a company with a record of helping the US agencies target ethnic minorities through immigration policy and racist policing.
Furthermore, there are plans in place to exercise what could reasonably be described as economic coercion to pressure people to “voluntarily” get vaccinated. Such coercion will be obviously be more effective on poor and working communities, meaning communities of color will be disproportionately affected as well.
Considering these facts, and the case for scrutinizing the safety of Oxford-AstraZeneca’s “affordable” vaccine option made above, any harm caused by vaccine allocation policy in the US and beyond is likely to disproportionately affect poor communities, especially communities of color.
As such, the public should take all vaccine rollout policy with a grain of salt, even when they come cloaked in language of inclusion, racial justice, and public health preservation. As the co-founder of the American Eugenics Society (later renamed “Society for the Study of Social Biology”) Frederick Osborn put it in 1968, “Eugenic goals are most likely to be attained under a name other than eugenics.”
JPost Fabricates Alleged Hezbollah Involvement in ISIL Captagon Ship Seized in Italy, Arab & Lebanese Media Outlets Endorse Slander
Al-Manar | December 26, 2020
The Zionist newspaper, Jpost, fabricated a report which alleged that Hezbollah was behind the captagon ship seized in Italy last July, knowing that the Italian authorities confirmed that drugs were made to fund the takfiri group.
JPost’s fabricated report was not confirmed by the Italian authorities which did not even comment on the rumors, according to Al-Manar correspondent in Italy.
The correspondent stressed that even the Italian media outlets disregarded JPost’s fabricated report , except a modest agency called Agenzia Nova which republished it so that the anti-Hezbollah media outlets in Lebanon and the Arab countries can endorse it.
Indeed, the anti-Hezbollah propaganda in Lebanon and the Arab countries waged a war of accusations against Hezbollah, knowing that the fabricated report has not been conformed by any Italian official.
Why are Tel Aviv and Washington Inflaming the Situation in the Persian Gulf?
By Vladimir Platov – New Eastern Outlook – 26.12.2020
During the run-up to the anniversary of the insidious assassination of Iranian General Soleimani – and after one month had passed since the equally controversial massacre of leading nuclear physicist Mohsen Fakhrizadeh – Israel and the United States, which are the ones responsible for this atrocity, are demonstratively increasing their military presence in the Middle East, and doing so in demagogic fashion under the guise of fearing “retaliation from Iran”.
The United States, located both at a considerable distance from Iran and outside the range of its missiles, having provoked this crisis clearly fears only a missile attack on its diplomatic mission in Iraq, as well as other American facilities in the region. Washington is trying to validate these fears with reports from American intelligence services, according to which pro-Iranian armed formations that can deliver a “retaliatory strike” have allegedly stepped up their activity in Iraq.
However, on December 21 Iranian Foreign Ministry spokesman Saeed Khatibzadeh denied these suspicions, which especially resounded in recent statements made by US Secretary of State Pompeo about the alleged complicity of pro-Iranian militia in the latest rocket strikes executed on Baghdad’s “Green Zone”. Along with that, Khatibzadeh wrote on Twitter that for Tehran “attacks on diplomatic facilities are unacceptable”.
Washington still dispatched additional warships and a squadron of fighters to the Middle East, and demonstratively conducted a nonstop flight of a B-52 strategic bomber that has the ability to carry nuclear weapons, by doing so intending to “intimidate Tehran”. In addition, on December 21 a US naval unit entered the Persian Gulf through the Strait of Hormuz that included a USS Georgia (SSGN 729) Ohio-class submarine, which carries up to 154 Tomahawk cruise missiles and is capable of taking on board up to 66 special operations service personnel, as well as two Ticonderoga-class guided-missile cruisers: a USS Port Royal (CG 73) and a USS Philippine Sea (CG 58). Previously, at the end of November, a USS Nimitz (CVN-68) aircraft carrier was sent off the Persian Gulf “to help contain the enemy”; this was rationalized by the need “to have additional defensive capabilities in the region in case of any unforeseen circumstances.”
As far as Israel goes, it clearly fears a “retaliation strike” from Iran since, given the Jewish state’s modest size, a successful attack on it could actually terminate its existence. This is especially true if the strike were to hit the Dimona Nuclear Research Center, which is considered to be the site where Israeli nuclear weapons originated; Tel Aviv neither confirms nor denies that the center exists. Incidentally, Ayatollah Mohammad-Ali Movahedi Kermani already delivered a warning to Israel that “if Iran decides to put up resistance, then one missile strike on the Dimona reactor would be enough”.
It is clear that Iranian missiles will not really be launched at Dimona, since this is fraught with consequences that entail nuclear contamination and destruction not only for Israel, but for Iran and quite a few neighboring countries across the region. And that is why the Iranian media occasionally names another target: the Israeli city of Haifa.
Israel, fearing the hysteria itself that potential military action could unleash, in a speech made by IDF Chief of General Staff Aviv Kochavi on December 21 cautioned Iran not to attack Israel, stating that “the Jewish state will retaliate against any aggression”.
Along with that, A. Kohavi evidently pointedly forgot to mention that it is not Iran, but Israel itself, that has already demonstrated its aggressive stance toward the Islamic Republic to the whole world by organizing and initiating acts of terrorism and assassinations – and not only against nuclear physicist Mohsen Fakhrizadeh. After all, this is far from the first time that Iranian scientists and leading representatives from Iranian society have been killed by an Israeli act of terrorism. For example, in Tehran, five nuclear physicists have been assassinated recently – and this specifically includes Hassan Tehrani Moghaddam, the architect of Iran’s ballistic missile program. All this points to the systematic destruction of the best Iranian scientists employed in the defense industry, which is being accomplished by the international community with impunity. This series of assassinations of prominent Iranian scientists, politicians, and military personnel – who ended up being unacceptable for the United States and Israel – substantiates the suspicions first voiced long ago that Western intelligence services and Israel have adopted the terrorist practice of eliminating key personnel and various prominent figures in those countries with which they are at war; this is done to weaken their defense systems and technological potential.
In addition to the words it speaks to help deter Tehran, Tel Aviv has taken a series of measures to test the combat readiness of its army against any potential foreign attacks, and is active about consulting with Washington – especially with representatives from the Pentagon – about how to work out joint coordination for the two countries to take military action against Iran. In particular, large-scale, unprecedented exercises came to an end in December, during which the capabilities of the three levels of Israel’s anti-missile defense (ABM) systems to neutralize various air threats were put to the test. Senior Israel Defense Forces officers, according to the Internet publication Breaking Defense, held “negotiations on coordination work” with their counterparts in the US Central Command (CENTCOM, which includes the Middle East) to bolster cooperation between the armed forces in the two countries “against Iran possibly taking revenge in the region”. According to this publication, Israel has reached its highest degree of readiness, in particular with regard to repelling “some of the 140,000 missiles that Iran-backed Hezbollah has in Lebanon, and the Houthi rebels in Yemen.” At the same time, it has been reported that although the Israeli command does not disclose the details about how it prepares for war, its tactical and operational anti-missile defense systems, and long-range missile systems, are still on high alert.
In addition, as reported by The Times of Israel, on December 17, Chairman of the Joint Chiefs of Staff Mark Milley arrived in Israel as part of his Middle East tour to discuss the threat that Iran poses to Washington’s allies, including the Jewish state.
As part of preventive measures taken against the armed situation in the region potentially escalating, Israel began to actively spread out its naval fleet around Iran. An Israeli Navy Dolphin-class (Type 800) submarine carrying cruise missiles on board passed through the Suez Canal, and on December 21 demonstratively surfaced in the Persian Gulf, in the waters that stretch between Saudi Arabia and Iran. Dolphin is a series of German modified diesel-electric submarines that are specially designed for Israel, and which have from 6-10 torpedo tubes. Besides torpedoes, they are armed with mines and Popeye Turbo SLCM cruise missiles that have a range of up to 1,500 km, and are capable of carrying nuclear charges with a capacity of up to 200 kilotons launched from torpedo tubes. The Israelis regularly keep at least two of their submarines.in the Indian Ocean, in the immediate vicinity of the Persian Gulf.
Today, in the assessments made by numerous experts, there is reason to presume that in January 2021, before Donald Trump [prospectively] leaves the White House, a joint American-Israeli missile strike could be launched against Iran, primarily to neutralize Iran’s air defense systems, as well as its nuclear industry facilities.
However, while ramping up the degree of military tension in the region Tel Aviv and Washington cannot help but clearly see that Iran does not intend to attack either the United States or Israel. Iran is not in an ideal condition to wage war now, since its economy is seriously undermined by the restrictive measures imposed on its oil sales abroad, as well as by the consequences of the coronavirus pandemic, the deficit inflicting its national budget, and the weakening of its national currency. Yes, military operations “against American and Israeli aggressors” can raise patriotic sentiments in the Islamic Republic for a certain period, but they would quickly drain the Iranian economy and militaristic zeal. In addition, hoping for a change in the attitude taken toward it after the White House administration [potentially] changes, for political and economic reasons it would now be clearly disadvantageous for Tehran to carry out any large-scale “retaliatory strike”. Therefore, the maximum that Tehran is capable of doing today, without causing itself significant damage, is to carry out a special operation against the Israelis involved in the murder of Mohsen Fakhrizadeh – or to inflict a targeted strike on American facilities in the region through its “proxies.”
As for the United States, Israel, and their allies taking military action against Iran right now, it should be kept in mind that the Islamic Republic, despite all its existing economic problems, is a pretty tough nut to crack in terms of its military, and aggression against it would have serious costs. And this cost is obviously unacceptable for either Trump or Netanyahu, who intend to keep pursuing their political careers.
Israel Strikes Pediatric Hospital in Gaza, Injures Palestinian Child
The Al-Durrah Pediatric Hospital in Gaza was damaged by Israeli airstrikes
Palestine Chronicle | December 26, 2020
A pediatric hospital, a center for disability services, and several homes were damaged early this morning in Israeli airstrikes and artillery attacks on the besieged Gaza Strip, Palestine Chronicle correspondent Wafa Aludaini reported.
Israeli warplanes fired five missiles east of the neighborhood of Tuffah in Gaza City injuring a six-year-old girl and a young man.
A fire broke out at the location of the airstrike as the firefighters worked all night to put out the fire in the attack that took place an hour after midnight. Electric power was also cut off to several areas east of Gaza as a result of the strikes.
Israel claimed the attacks came after two missiles were fired from Gaza and fell in open areas in southern Israel without causing any damage or injury.
“It was a horrible night for the children at the Al-Durrah Hospital, due to the missiles fired by the Israeli occupation warplanes, which caused deep damage to the hospital, spreading fear and panic among children and their families,” Dr. Majed Hamadah, manager of the hospital, told our correspondent.
“This is not the first time that the Al-Durrah Hospital has been bombed by the Israeli occupation, despite the fact that it is a pediatric hospital,” Dr. Hamadah added.
India arrests 75 in restive Kashmir following local polls
Press TV | December 26, 2020
Indian authorities have arrested at least 75 Kashmiri political leaders and activists in anticipation of an uprising following the triumph of an alliance of Kashmir’s regional political parties in a local election, a senior police official unveiled.
Those arrested included pro-independence leaders and members of the banned Jamat-e-Islami group, who were rounded up in what the government described as preventive custody, the official told Reuters on the condition of anonymity.
The detentions challenge the verdict of the people, said Imran Nabi Dar, spokesman for regional party, the National Conference, and a key member of the alliance.
The District Council election that ended early this week was the first such exercise since the government of India’s ultra-nationalist Prime Minister Narendra Modi revoked the special status of the Muslim-majority region under its control last year.
Authorities in New Delhi then waged a crackdown on opposition activists in the restive region and rounded up hundreds of people in purported efforts to forestall protests and violence.
The alliance’s latest victory confirms that Kashmiris have not accepted Modi’s decision to end Kashmir’s special status, said Omar Abdullah, a former chief minister and head of the National Conference.
Following their release from prolonged detention, Abdullah and Mehbooba Mufti, chief of the Jammu and Kashmir People’s Democratic Party, announced the alliance in October aimed at seeking a peaceful restoration of Kashmir’s autonomy.
Meanwhile, the elections in Kashmir appear to have paved the way for other electoral processes in the volatile region. However, many say this ballot has made people of Kashmir politically aware of the fact that New Delhi is trying to thrust such an electoral process in order to create the impression that normalcy has taken hold after it stripped Kashmir of its autonomy, without actually working on building trust and bridging the gaps.
India last year scrapped the semi-autonomy of its part of Kashmir. New Delhi unilaterally introduced a slew of laws that locals say are aimed at shifting the region’s demographics and economically disempowering local residents.
Modi’s government revoked the New Delhi-controlled Jammu and Kashmir’s special status last year and claimed at the time that ending Kashmir’s special status was necessary for closer integration of the territory into the rest of India.
New Delhi’s approach towards the region has been widely criticized as being an extension of its tolerating instances of egregious discrimination and occasional deadly attacks against Muslims on the mainland.
Kashmir has long been a flash point between India and Pakistan, which have fought three of their four wars over the disputed Himalayan territory. Both countries rule parts of Kashmir while claiming it in full. Thousands of people have been killed since early 1990s.
The subject of Israeli hegemony over US must be addressed
By Walt Peretto | Press TV | December 25, 2020
It’s pardon season for President Trump. The likely outgoing president has issued 15 pardons that include two members of the Russian investigation and four convicted murderers who worked for the private security firm Blackwater.
These four were convicted of murdering 14 Iraqi civilians in 2007. Private security corporations such as Blackwater (since renamed Academi) have played a major role in war zones since the invasions of Afghanistan and Iraq after the false flag events of 9/11/2001. They are also suspected of participation in other domestic false flag events that include the Boston Marathon event in 2013.
These pardons by Trump will facilitate the use of private security firms in the near future both domestically and abroad. Further lockdowns in the US and crushing strains on small business may create unrest which could overwhelm municipal law enforcement and the federal government may choose to hire private security to deal with such occurrences. Overseas, tensions may increase in Syria as the new Democratic president may resurrect the goal of toppling President Assad which would likely be carried out by hiring private mercenaries which the West has done in the past.
I think these pardons by Trump send a signal to private security firms that their actions will not be hampered by long prison sentences for employees who engage in murder. Similar to municipal policing in which cops that murder are virtually never convicted. If the US does rededicate itself to regime change in Damascus, it’s hired security forces and clandestine paid terrorists don’t want restraints like convictions of murder in the courts.
Trump’s pardon of two people involved with the Russiagate fiasco makes sense since Russian collusion was never proven and the whole story was really a distraction for 4 years designed to take people’s eyes off of leaked emails involving Hillary Clinton, the Podesta brothers, Barack Obama and others that were quite damning if they were thoroughly investigated.
For four years the left-leaning media in the United States filled the news with accusations of Russian collusion in US elections and other illegal and immoral interactions between Russian officials and the Trump administration.
This also kept the eye off the elephant in the room called Israel which has seized control of the presidency, the Congress, the Judiciary, the economy through the FED, and the mainstream media.
China has provided another useful distraction from Israeli influence in America. If one honestly examines recent US presidential administrations — don’t strain to find any Chinese or Russian nationals in positions of power in the US federal government. Dual US/Israeli citizens are abundant and ubiquitous in the Trump administration and it will be similar in the Biden administration if he makes it to the White House. The subject of Israeli hegemony over the United States is a subject no one seems to want to address.
Judging from the proposed COVID Stimulus Package which allocates billions of dollars to other countries, this proves that the globalist intention is to bleed the United States dry until it submits wholly to the international cabal of psychopaths that includes Klaus Schwab and his World Economic Forum who are attempting to reset the world into a one-world system led by global organized psychopathy.
China does not have allies, but has friends with partnership diplomacy
By Xue Li – Global Times – 2020/11/8
The Wall Street Journal published an article earlier this month entitled “China’s Risky Bet on a Lonely Return to Greatness,” suggesting China has no friends. China does not have allies indeed, but it doesn’t lack of friends. This is not only because of China’s historical tradition and the current international environment, but also because of China’s own choices.
Based on Christian monotheism, the spirit of Roman law and Greek formal logic, Western civilization largely views problems and world order from the perspective of binary opposition. Therefore, they prefer forming alliances in diplomacy so as to restrain and even assimilate allies through mandatory mechanisms. This allows them to confront and even defeat the non-allies.
At the same time, they firmly believe that every country must have a similar diplomatic philosophy, so it is necessary to encircle and even disintegrate emerging powers. They not only try to equate the history of Christian expansion since the maritime exploration during the age of discovery with the universal history of humanity, but also view the diplomatic concept of the Christian civilization over past 500 years as the world’s universal diplomatic philosophy. They do not realize that 500 years is a relatively short period in the history of human civilization, and that different civilizations have different views on diplomacy world order.
During the Han Dynasty (206BC-AD220), Taoism and Confucianism are the main concepts on which Chinese civilization is used to view issues, advocating the construction of an order through rule of ritual. Therefore, China has few diplomatic alliances, and it advocates that countries should adjust their ties according to specific situations. In diplomatic operations, China emphasizes that a country should believe in the charm of their own values and civilization, rather than forcefully imposing their own values and systems onto others.
In the past 500 years, some European countries became global empires through colonial expansion by means of force. The US has become a superpower after the end of the two world wars through building alliance systems. With the changing times and the emergence of nuclear weapons, it’s impossible for China to copy the emergence of European countries or the approaches of the US. One feasible option to realize the rejuvenation of Chinese civilization would be to expand its overseas interests in a way that is acceptable to the host country – whether with general policies, economics, and culture.
In modern times, China once allied itself with other countries. Those alliances were not systematic and continuous, and the outcomes were not ideal enough. China thus gave up diplomatic alliances, and carried out its non-aligned diplomacy in 1960s and 1970s, independent foreign policy of peace in 1980s, and partnership diplomacy since 1990s.
Chinese civilization is a kind of regional civilization. Although it has global influence in some aspects, it lacks the gene of global expansion of monotheistic civilizations. Perhaps because of the reasons mentioned above, Chinese leaders have repeatedly stressed that China has no intent to replace any other country in the world. But Western countries will take a long time to accept this.
Partnership diplomacy meets the needs of the contemporary world. On the road of rejuvenation, China firmly believes that partnership diplomacy is a better and more suitable choice for itself than alliance diplomacy. So far, 112 countries and international organizations have established partnerships with China. This number will undoubtedly continue to increase. Partnership diplomacy has become a prominent feature of China’s diplomacy.
After the Belt and Road Initiative was proposed in 2013, China’s diplomacy has changed from maintaining a low profile to becoming more proactive in global affairs. But the policy of “partnership rather than alliance” has not changed, and it is unlikely to change in the future. The indisputable fact is that the system of alliance diplomacy preferred by Western countries is the choice of a few countries in the world, and most countries choose non-aligned diplomacy. Besides, the vast majority of them are developing countries in Asia, Africa and Latin America.
The world has entered a long period of competition and cooperation among civilizations. It is necessary for the West to think outside the box instead of seeing the world from the perspective of Christian civilization, and learn to put itself into China’s position. Only in this way can the West truly understand the Chinese civilization and contemporary China, and base the relationship between China and the West on an accurate judgment and a relatively solid foundation so as to reduce misunderstandings and conflicts, and increase cooperation and mutual benefits.
The author is director of the Department of International Strategy at the Institute of World Economics and Politics under the Chinese Academy of Social Sciences. opinion@globaltimes.com.cn
Featured Video
9/11 In Perspective
or go to
Aletho News Archives – Video-Images
From the Archives
Still No End in Sight of the Murder and Mayhem Wrought by the 9/11 Culprits
By Prof. Tony Hall | American Herald Tribune | July 17, 2016
The Kevin Barrett-Chomsky Dispute in Historical Perspective – Fourth part of the series titled “9/11 and the Zionist Question”
Back in 2006 all but a prescient few, such as Christopher Bollyn, perceived it as premature to try to identify and bring to justice the actual perpetrators of the 9/11 crimes. There was still some residue of confidence that responsible officials in government, law enforcement, media and the universities could and would respond in good faith to multiple revelations that great frauds had occurred in interpreting 9/11 for the public.
Accordingly, the main methodology of public intellectuals like Dr. Kevin Barrett or, for instance, Professors David Ray Griffin, Steven E. Jones, Peter Dale Scott, Graeme MacQueen, John McMurtry, Michael Keefer, Richard B. Lee, A.K. Dewdney, Nafeez Mossadeq Ahmed, and Michel Chossudovsky, was to marshal evidence demonstrating that the official narrative of 9/11 could not be true.
The marshaling of evidence was spurred on by observations coming from government insiders like Eckehardt Wertherbach, a former head of Germany’s intelligence service. In a meeting in Germany with Christopher Bollyn and Dr. Andreas von Bülow, Wertherbach pointed out that, “an attack of this magnitude and precision would have required years of planning. Such a sophisticated operation would require the fixed frame of a state intelligence organization, something not found in a loose group like the one led by the student Mohammed Atta in Hamburg.”
Andreas von Bülow was a German parliamentarian and Defense Ministry official. He confirmed this assessment in his book on the CIA and 9/11. In the text von Bülow remarked that the execution of the 9/11 plan “would have been unthinkable without backing from secret apparatuses of state and industry.” The author spoke of the “invented story of 19 Muslims working with Osama bin Laden in order the hide the truth” of the real perpetrators’ identity. … continue
Blog Roll
Aletho News- Kaja Kallas: an uncomfortable figure useful to the EU’s Russophobic purposes
- German state blacklists right-wing party for first time
- Romania’s stolen elections were only the start: Inside the EU’s war on democracy
- Hawaii bills would allow gov’t to quarantine people, enter property without permission, seize firearms, and suspend laws
- Epstein files may contain ‘crimes against humanity’ – UN
- UK Government Plans to Use Delegated Powers to Undermine Encryption and Expand Online Surveillance
- Epstein Files Expose Israeli Occupation of America
- The Mandelson Molecule: Exposing the Architecture of Cross-Border Political Suppression
- The U.S. Sanctions Cuban Journalist For Reporting On The U.S. Blockade
- Israeli firms transform cars into intelligence devices: Reports
- If Americans Knew
- Why won’t Trump’s “Board of Peace” bring peace? – Not a ceasefire Day 131
- Help end the injustice against Shadi
- Israel’s Favorite American President
- Israel’s “Yellow Line” Is a Death Trap for Palestinians. We Drove Into It.
- Why Israel’s expanding occupation in Syria presents a critical legal test
- Gaza is not a natural disaster. It is the victim of genocide enabled by global inaction
- Netanyahu’s plan to “end” US aid to Israel is to give even more money under a different name
- Israel ceased firing on Gaza for just 15 days of the “ceasefire” – Not a ceasefire Day 130
- In Gaza, “rats run over our faces” – Not a ceasefire Day 129
- Israel-backed border guards, GHF-linked aid – Not a ceasefire Day 128
- No Tricks Zone
- Coal Power Back In Trend As Globe Tries To Keep Pace With Growing Demand For Power
- New Study: A 4°C Warmer Beaufort Sea Had ‘No Sea Ice’ 11,700 – 8200 Years Ago
- Unfudging The Data: Dutch Meteorological Institute Reinstates Early 20th Centruy Heat Waves It Had Erased Earlier
- German Gas Crisis…Chancellor Merz Allegedly Bans Gas Debate Ahead of Elections!
- Pollen Reconstructions Show The Last Glacial’s Warming Events Were Global, 10x Greater Than Modern
- Germany’s Natural Gas Storage Level Dwindles To Just 28%… Increasingly Critical
- New Study Rebuts The Assumption That Anthropogenic CO2 Molecules Have ‘Special’ Properties
- Climate Scientist Who Predicted End Of “Heavy Frost And Snow” Now Refuses Media Inquiries
- Polar Bear Numbers Rising And Health Improving In Areas With The Most Rapid Sea Ice Decline
- One Reason Only For Germany’s Heating Gas Crisis: Its Hardcore-Dumbass Energy Policy
Aletho News 